We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.85B
Cap. Flow %
-89.66%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.1 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Top Buys

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK icon
Splunk Inc
SPLK
+$446M
3
HES icon
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X icon
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Miscellaneous 10.26%
5 Real Estate 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
DOCU icon
151
DocuSign
DOCU
$13.3B
$2.08M 0.07%
+35,000
New +$1.61M
2023 Q4
0 quarters
SNDX icon
152
Syndax Pharmaceuticals
SNDX
$1.52B
$2.07M 0.07%
+95,949
New +$1.47M
2023 Q4
0 quarters
FUSN icon
153
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$2.05M 0.06%
213,107
-61,461
-22% -$299K
2022 Q3
5 quarters
BZAI icon
154
Blaize Holdings
BZAI
$42.6M
$2.02M 0.06%
187,581
-84,314
-31% -$897K
2022 Q1
7 quarters
ODFL icon
155
Old Dominion Freight Line
ODFL
$37.7B
$1.99M 0.06%
+9,800
New +$1.94M
2023 Q4
0 quarters
SLAM icon
156
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$1.98M 0.06%
182,628
-82,344
-31% -$893K
2021 Q2
10 quarters
PLD icon
157
Prologis
PLD
$123B
$1.98M 0.06%
14,848
-37,697
-72% -$4.28M
2022 Q2
6 quarters
TMCI icon
158
Treace Medical Concepts
TMCI
$257M
$1.98M 0.06%
154,913
-18,091
-10% -$183K
2022 Q1
7 quarters
PODD icon
159
Insulet
PODD
$9.38B
$1.96M 0.06%
9,047
-5,353
-37% -$918K
2023 Q3
1 quarter
GEHC icon
160
GE HealthCare
GEHC
$29.7B
$1.95M 0.06%
25,203
-39,132
-61% -$2.74M
2022 Q4
4 quarters
VSAC icon
161
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$1.94M 0.06%
175,381
-78,831
-31% -$872K
2022 Q1
7 quarters
KRC icon
162
Kilroy Realty
KRC
$3.98B
$1.93M 0.06%
+48,336
New +$1.59M
2023 Q4
0 quarters
DCPH icon
163
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.9M 0.06%
117,920
-35,817
-23% -$457K
2022 Q3
5 quarters
IMCR icon
164
Immunocore
IMCR
$1.51B
$1.89M 0.06%
27,641
-11,704
-30% -$608K
2022 Q1
7 quarters
ANAB icon
165
AnaptysBio
ANAB
$1.37B
$1.87M 0.06%
87,124
-37,339
-30% -$644K
2022 Q1
7 quarters
LCID icon
166
PUT
Lucid Motors
LCID
$1.49B
$1.85M 0.06%
75,000
– –
2023 Q2
2 quarters
CSCO icon
167
Cisco
CSCO
$467B
$1.84M 0.06%
36,506
– –
2023 Q3
1 quarter
CDLX icon
168
Cardlytics
CDLX
$12.1M
$1.84M 0.06%
+20,000
New +$2.03M
2023 Q4
0 quarters
MDT icon
169
Medtronic
MDT
$113B
$1.84M 0.06%
22,328
-37,468
-63% -$2.86M
2023 Q1
3 quarters
KDK icon
170
Kodiak AI
KDK
$335M
$1.78M 0.06%
170,767
-76,755
-31% -$794K
2023 Q2
2 quarters
LTC icon
171
LTC Properties
LTC
$2.29B
$1.78M 0.06%
55,297
-92,443
-63% -$2.99M
2023 Q1
3 quarters
CSTA
172
DELISTED
Constellation Acquisition Corp I
CSTA
$1.78M 0.06%
160,688
-72,679
-31% -$800K
2021 Q1
11 quarters
KNSA icon
173
Kiniksa Pharmaceuticals
KNSA
$6.22B
$1.77M 0.06%
100,722
-5,701
-5% -$93.7K
2022 Q3
5 quarters
INSM icon
174
Insmed
INSM
$22B
$1.76M 0.06%
56,727
-2,565
-4% -$66.5K
2022 Q1
7 quarters
PHYT icon
175
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$1.76M 0.06%
159,438
-95,552
-37% -$1.05M
2022 Q1
7 quarters
5 6
7
8 9

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.